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Abstract
Currently, migrants and other mobile individuals, such as migrant workers and asylum seekers, are
an expanding global population of growing social, demographic and political importance. Disparities
often exist between a migrant population's place of origin and its destination, particularly with
relation to health determinants. The effects of those disparities can be observed at both individual
and population levels. Migration across health and disease disparities influences the epidemiology
of certain diseases globally and in nations receiving migrants. While specific disease-based
outcomes may vary between migrant group and location, general epidemiological principles may be
applied to any situation where numbers of individuals move between differences in disease
prevalence. Traditionally, migration health activities have been designed for national application and
lack an integrated international perspective. Present and future health challenges related to
migration may be more effectively addressed through collaborative global undertakings. This paper
reviews the epidemiological relationships resulting from health disparities bridged by migration and
describes the growing role of migration and population mobility in global disease epidemiology. The
implications for national and international health policy and program planning are presented.
Introduction
The relationships between disease, travel and migration
have historical roots that continue to influence modern
medical activities [1]. Traditional medical approaches
dealing with migrant health have focused on the recogni-
tion, identification and management of specific diseases,
illnesses or health concerns in mobile populations at the
time and place of their arrival [2]. These activities have
often been based on the principles of protecting the recip-
ient population through policies of exclusion directed at
the migrant or arriving traveller. Derived from the histor-
ical practices of quarantine, similar processes continue in
a modern context through immigration medical screening
[3] and border control practices intended to reduce threats
to public health or to mitigate potential impacts on
healthcare services.
The epidemiological analysis of illnesses and disease in
migrants is most commonly approached in one of two
ways in receiving countries. The first is to consider the
health issue of concern in terms of the status at the time of
migration, while the second is to study the evolution of
the health characteristic over time [4]. The reference pop-
ulation for the first analytical approach is normally the
host or receiving population, while the reference group
for the second approach can be either the host population
or a comparison cohort at the migrants' place of origin
(see table 1).
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The quarantine-associated historical basis of migration
health practices has ensured that much of the interest in
health and migration has been directed towards commu-
nicable diseases [5]. Commonly, migrant medical screen-
ing focuses on conditions differentially prevalent between
the migrant and host population, such as tuberculosis [6],
leprosy [7], or syphilis [8]. Medical screening has been
used to quantify and document aspects of health and dis-
ease in migrant cohorts, most often in relation to national
public health statistics. Over time, these studies have
described some of the immediate and long-term impacts
of population movement in individual migrant receiving
nations.
Recently, the growing international importance of migra-
tion has stimulated new interest in other aspects of
migrant health. In addition to communicable diseases,
attention is now focused on pre-existing non-infectious
diseases [9] and other health domains, including behav-
iour [10], morality [11] and genetic or ethnic profiles [12]
in migrant populations. Epidemiological studies now
involve chronic illnesses [13] such as malignancies [14],
renal failure [15] and severe cardiac disease [16], as well
as mental and psychosocial health [17] and maternal and
child health [18]. Lifestyle-associated health issues,
including tobacco use, alcohol consumption and sub-
stance abuse, are also being examined in relation to the
process of migration in some migrant receiving countries
[19].
As migrant demographics often vary between receiving
nations, international comparisons involving the pooled
analysis of several host nations would be challenging in
interpretation and of questionable utility. However, inter-
est in the global implications of the epidemiological
aspects of migration is growing [20]. The increasing desire
for improved information is, however, complicated by the
greater diversity now manifest in modern migrant popu-
lations. In additional to traditional immigrants, current
mobile populations are often comprised of several other
cohorts that are not similarly distributed between migrant
receiving nations. Those other groups include refugees
and asylum seekers, temporary migrants such as interna-
tional students and migrant workers, and complex groups
of irregular or illegal migrants, including those who have
arrived through smuggling or trafficking.
The current volume and diversity in migration often
exceeds the scope and intent of the traditional methods
used to assess and manage health issues in immigrants. As
a consequence of this more diverse demographic and
fluid environment, the perspectives derived solely from
traditional immigrant medical screening practices may be
limited. These limitations may be overcome by applying
population health principles to the study of migration, a
process that may result in observations that are more
applicable to immigration health policy and programme
development [21].
A population health-based approach considers the rela-
tionship between migration and health as a progressive,
interactive process influenced by temporal and local vari-
ables. The observations are less related to the administra-
tive mechanics of migration [22] and more sensitive to the
driving forces that cause people to migrate. A population-
based approach also facilitates the consideration and
study of the long-term consequences of movement
between locations with different health determinants and
health outcomes. Use of this approach supports the exam-
ination of the issues from a global perspective. Such meth-
odologies are already in use in the health sector. The
Global Fund approach to tuberculosis, malaria and HIV
similarly represents an integrated, inter-regional action
plan in the face of persistent global health challenges [23].
As presented below, considering migration-relevant dis-
eases in terms of population-based risk may be more rele-
vant to disease control programs than time-of-entry
screening for individual conditions. Evaluating the migra-
tion and mobility history of populations has the addi-
tional advantage of supporting longitudinal analysis of
health characteristics. This context is important in the
consideration of illnesses and diseases with long latency
or delayed diagnostic time [24], an area beyond the scope
of traditional time-of-entry immigration screening. It also
facilitates investigation of the acquisition of positive and
negative health attributes by migrants following arrival
[25], which is also of increasing interest in migration
Table 1: Epidemiological approaches to health and migration
Time Period Epidemiological 
Characteristic
Reference Population
Arrival Phase (Point Prevalence) Prevalence Host/Receiving population
Post Arrival Phase (Point Prevalence 
or Longitudinal Studies)
Incidence/Prevalence Similar non-migrating cohort at 
migrants' place of origin
Host/Receiving populationEmerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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health. Finally, population-based methods reflect the
nature and role of globalisation and can be used to sup-
port and rationalise strategies to deal with health chal-
lenges at their source.
The population health approach to migration health is
based on the standardised examination of two factors: (1)
sustained disparate health environments and (2) the
movement of populations between regions of differential
prevalence of health indicators and outcomes.
The dynamics of health disparities
Some diseases or illnesses are sustained by differences that
are purely geographic or environmental in origin. In other
situations, differences in health outcomes, and the factors
that determine or influence health outcomes, result from
more complex interactions. The environment [26], socio-
economics, genetics and biology, and behavioural factors
influence population measurements of disease prevalence
individually and in combination.
Examples of environmentally-limited diseases include
vector-borne conditions, for which environmental factors
determine the distribution of disease transmission, as
observed in the global epidemiology of malaria, Chagas'
disease, yellow fever and West Nile Virus. Environmen-
tally-related non-communicable disease epidemiological
disparities include micronutrient deficiencies [27] and
geographically-defined exposure risks, such as health out-
comes related to extreme weather or altitude [28]. Move-
ment of the population out of the risk environment (i.e.
African refugees in Europe and North America and
malaria) or establishment of disease transmission outside
of the usual environmental constraints (i.e. West Nile
Virus in North America) will impact on the epidemiology
of the condition in the receiving region and on the local
population health outcomes.
Social and economic influences can be significant factors
in the creation and maintenance of differences in health
and disease outcomes between populations. Poverty, edu-
cation, housing and nutrition are directly related to dis-
ease prevalence and illness outcomes [29]. The capacities
and capabilities of medical and health sectors can affect
health through the availability, accessibility [30] and
affordability of health promotion, disease prevention and
treatment services [31,32]. Additional factors that influ-
ence health risks and outcomes include language skills
[33], behavioural and cultural practices [34,35], such as
the use of tobacco, dietary practices and population
norms for body mass and physical exercise [36].
Migrants and other mobile populations reflect the health
characteristics of their place and environment of origin
and carry several of these characteristics with them when
they move [37,38]. In addition, migrants are also subject
to other specific influences that may affect their health.
These factors result from the process of migration itself,
for example, during the travel phase between origin and
destination. This is frequently observed in refugees, dis-
placed persons and disadvantaged migrant populations
such as trafficked or smuggled persons [39-41], and
includes events such as trauma and torture [42,43]. Other
migration-specific health influences are observed in
migrant worker populations [44,45], the children of
migrants [46] and returning travellers who have been vis-
iting family and friends [47]. A demographic and mobility
process approach to these considerations is presented in
table 2.
The impact of genetic and biological determinants of
health and disease may be intuitively self-evident. How-
ever, in non-endemic regions these influences, and their
linkages to population mobility, may be poorly appreci-
ated in the early phases of migration due to lack of aware-
ness, knowledge or experience in the healthcare delivery
sector [48].
Disparities in health determinants and disease outcomes
are not absolute, but change over time. This temporal var-
iability adds an important dimension of complexity to the
analysis and investigation of migrant health concerns,
which can affect cohort comparability. Economic and
social environments can change rapidly in the modern
world. If those changes influence health determinants,
consequential changes in health outcomes can be
observed over relatively short periods of time. For exam-
ple, in the thirty years following 1965, the difference
between life expectancy for males in the United Kingdom
and Russia increased by more than ten years (range from
3.6 to 15.1 years) [49]. Basic public health improvements
such as the provision of adequate, safe drinking water,
improved sewerage and housing can significantly reduce
the incidence and prevalence of diseases of major public
health importance in the space of less than a generation
[50]. Similarly, conflict, environmental change, natural
disasters and population growth can result in new risk
exposures and acquisition of adverse health outcomes
over short time periods [51]. Genetic admixture and
behavioural characteristics of individuals and popula-
tions that impact on health outcomes can also occur sin-
gly and in combination with other determinants vary over
time.
These rapid temporal changes influence the epidemiology
of health disparities. If they take place against a back-
ground of sustained or growing migration, they may also
influence the interpretation of longitudinal and compara-
tive studies involving migrants. Health outcomes for cur-
rent departing migrants may differ significantly fromEmerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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previous cohorts originating at the same location, as
health indicators change over time at the migrants' place
of origin. Depending on the nature of the local changes,
either improved or worsening health characteristics in cur-
rent migrant cohorts may be observed. Examples of this
''time phase'' phenomenon can be seen in the improved
population health indicators of several Asian nations that
have occurred following recent trends in large-scale migra-
tion from Asia to Europe and North America. Some of
these changes are significant, as indicated by the changing
mortality data due to hypertensive cardiac disease in
Korea. During the interval between 1984 and 1999, the
age-adjusted mortality for hypertensive cardiac disease in
Korean men decreased by 92% (from 51.6 to 4.1/
100,000) and 84% for women (from 34.1 to 5.3/
100,000) [52]. By contrast, examples of diminishing lev-
els of good health indicators can be observed in some
Central and Eastern European nations in the period fol-
lowing the dissolution of the Soviet Union [53].
Modern migration and population mobility
While migration has always been a fluid process subject to
change, these changes must now be assessed in terms of
the rate of change and global magnitude of population
movement. During the past 50 years, the process of migra-
tion and concomitant movement of other mobile popula-
tions has been markedly influenced by:
1. The decolonialisation of many nations, including those
in Africa, the Middle East, Asia, Latin America and the Car-
ibbean;
2. Large refugee movements following conflicts and civil
disturbances, including South East Asia, the Balkans, Cen-
tral America and Central Africa; and
3. The political, social and economic consequences of the
collapse of the former Soviet Union.
As a result of these events, between 1960 and 2000 the
legal and administrative restrictions on the ability to
travel, work and move internationally have changed for
hundreds of millions of individuals. This has been associ-
ated with a profound shift in the demography of people
on the move and the nature of migration itself [54]. In tra-
ditional migrant-receiving regions such as Australia and
North America, patterns of migrant origin have shifted
from Europe to source countries in Asia, Africa, Central
and South America and the Middle East [55] in the time-
span of little more than one generation.
Table 2: The impact of different health environments and the phases of population mobility
Occurrence Examples Consequence at Destination
Pre-departure existing medical condition - prevalence of endemic disease
- level of development
- access to care
- availability of care
Arriving population displays health indicators of 
origin:
• Differing incidence and prevalence of illness
• Differences in awareness of and use of 
healthcare services:
• preventive
• promotional
• diagnostic
• therapeutic
Health impacts during migration - trauma (physical-psychosocial)
- deprivation
- violence
- exposure
- injury
Some populations display greater prevalence of 
illness resulting from torture, trauma, abuse 
and exposure
• Refugees
• Refugee claimants or asylum seekers
• Trafficked/smuggled migrants
Health impacts arising after arrival administrative/legal limits
- poverty
- language culture
- occupational risks
Awareness of and use of healthcare services in 
migrant populations may be limited by 
immigration status, poverty, language and 
culture
Working conditions may be associated with 
health risks:
• Migrant agricultural labor
• Commercial sex workers
• Illegal workers
• Trafficked migrants
Health consequences of return travel Health environment at origin may have changed
- health systems improvements or declines
Children born to foreign-born parents have no 
exposure to risks present at origin
Populations making return journeys to place of 
origin (particularly children born at new 
destination) may be at increased risk of disease 
or illness:
"Visiting friends and relative" travellers
- Locally born children of foreign-born parentsEmerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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This evolution has not been limited to regulated, tradi-
tional immigration and emigration. It has also involved
refugee and humanitarian movements and an increase in
irregular arrivals (refugee claimants, asylum seeking,
smuggling and trafficking in humans). Complex humani-
tarian emergencies are often associated with large popula-
tion displacements of refugees, humanitarian evacuees
and other displaced populations. Unlike refugee move-
ments before the Second World War that were often pas-
sive, modern international attention and efforts are
frequently directed at assisting the international reloca-
tion of vulnerable migrant populations. International
organisations such as the United Nations High Commis-
sion for Refugees [56] and the International Organization
for Migration [57], as well as other infrastructures, now
support and facilitate the selection, movement and reset-
tlement of these populations. These activities are now glo-
bal in scope and planning, involve an increasing number
of nations and, when triggered, take place more rapidly
than historical refugee resettlements [58].
Against this backdrop of political, social and civil societal
change, the nature, speed and access to international
travel has also undergone marked evolution. Travel pat-
terns have been affected by changes in transportation
technology, accessibility, and affordability. Growth in air
travel has functionally reduced previous limits on the
rapid international movement of large numbers of indi-
viduals. In 1960, there were approximately 70 million
international journeys globally. The number of similar
international journeys in 2004 was in excess of 760 mil-
lion [59]. The high volume of international travel sup-
ports greater population exchange and return flows
between migrant origin and destination locations.
Increased international travel has also been an integral
component of the growing process of globalisation. The
progressive integration of global economic and commu-
nications sectors has been accompanied, if not preceded
by, a corresponding growth in the international demand
and flow of labour and manpower. The International
Labour Organization estimates the foreign-born migrant
labour force to be nearly 90 million persons worldwide
[60]. In several locations, there is a repetitive flow of
workers between regions of origin and regions of employ-
ment. Some of these movements are regular and organ-
ised. However, modern population pressures and
economic push-pull factors related to marked global dif-
ferences in opportunity are increasingly associated with
irregular population flows facilitated by either smuggling
or trafficking of those seeking a better life [61].
Another recent series of factors affecting population
mobility and migration has resulted from geo-political
changes such as the collapse of the former Soviet Union
[62]. The resulting economic, social and political conse-
quences have both direct and indirect impacts on the
demography and movement patterns of migrants to West-
ern Europe, parts of Middle-East Asia and the Americas
[63]. Current immigration, family reunification and
return dynamics in Europe and Central Asia are pro-
foundly different from those of only two decades previ-
ously. These changes have been manifested in both
voluntary migration, such as that observed in migrants
from the former Soviet Union to Israel [64], as well as the
flow of refugees and those displaced by regional conflict,
as exemplified in the Balkans in the mid to late 1990s
[65].
The epidemiological consequences of mobility across 
differentials in disease prevalence
In much of the developed world, infections that were his-
torically significant causes of illness and death have
decreased in incidence and prevalence or been eliminated.
This was accomplished through sanitation, immunisa-
tion, antibiotic therapy, and improved healthcare and
public health practices. By the end of the last millennium,
several globally important infections had reached the
point where they were no longer of public health signifi-
cance in economically advantaged areas of the world. In
some areas of the developed world, domestic transmis-
sion of serious infectious diseases, such as measles [66]
and polio [67], has been eliminated. This is far in advance
of what was observed or possible in the developing world.
This can create enormous differences in the prevalence of
certain conditions between locations. In a mobile world,
travellers and migrants crossing these prevalence gaps can
become the source for outbreaks of these diseases [68].
The creation of such prevalence differences is not limited
to communicable diseases. The ability to treat and man-
age non-infectious diseases in highly developed regions of
the world likewise differs from the situation in many
developing regions. Access to and use of complex and
costly interventions, such as cancer treatment, organ sys-
tem support, transplantation and extensive pharmaco-
therapy vary according to levels of national economic
development. These disparities in social investments in
health services availability and population access to
healthcare are associated with several differential inter-
regional health outcomes, including premature death and
increased morbidity in the developing world [69].
In the absence of extensive international travel, popula-
tion mobility and migration, the effects of differences in
disease prevalence would have limited global significance.
Nations and regions would strive to improve their domes-
tic health capacities and reduce the domestic burden of
disease and illness within their population much as they
have done throughout history. However, expanding travelEmerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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and migration across these prevalence differentials now
function as an increasing, population-based bridge
between the disparities. The net result is the global exten-
sion of what was predominantly a local risk.
The global extension of regional epidemiological differ-
ences can have marked impact on the local epidemiology
of disease. Examples include tuberculosis, sexually-
acquired infections, Chagas' disease and strongyloidiasis,
for which foreign-born migrants from hyper-endemic
areas represent the majority of national case burden in
low incidence or non-endemic nations [70-73]. Similar
patterns of epidemiological evolution exist for other long-
term infections such as hepatitis B and C, as well as HIV/
AIDS in some European nations, where these diseases are
reported to be more common in foreign-born migrants
than in native-born residents [74-76].
Migration-related epidemiological influences on domes-
tic disease patterns for migrant-receiving nations are also
observed for non-infectious diseases [77]. Migrants arriv-
ing from less developed regions of the world may have
had less access to preventive care, health promotion pro-
grammes, and diagnostic or therapeutic interventions for
illness and disease. Cancer detection programs [78] and
periodic health examinations may not be commonly
accessible in many populations. Access to healthcare pro-
viders and basic services are unequally distributed or sub-
ject to limited availability in many places. Similar
differences in availability can be observed for smoking
and substance abuse prevention programmes, pro-
grammes to detect and manage vitamin or micronutrient
deficiencies, promotion of dental health and programmes
to manage genetic or biological conditions [79]. As a con-
sequence, migrants may present with disease in more
advanced stages than normally observed by providers in
the destination country [80].
In considering migration in a population health context,
it is important to note that not all of the migration-associ-
ated epidemiological changes relate to situations where
the migrants are less advantaged than the host popula-
tion. In terms of lifestyle-related non-infectious illnesses,
many migrants and new arrivals display health parame-
ters that are better than those of the receiving population
[81]. Over time and resulting from a variety of factors
including acculturation, diet and behavioural changes,
immigrant populations may acquire and display common
adverse health indicators more similar to those of the
receiving population [82]. Ironically, some of the benefi-
cial factors arriving with immigrants may be adapted
locally to the general benefit of the host population, but
may be lost over time in immigrant population and their
locally-born children.
Temporal effects of migration on local health and disease 
epidemiology
Migration-associated influences on the epidemiology of
disease have both immediate and long-term effects on
host country health indicators due to differentials in dis-
ease prevalence, as well as magnitude factors associated
with population census shifts (because of the number of
migrants and births to the foreign-born cohort). For dis-
eases of rare or limited occurrence, particularly where
national incidence has been reduced to very low levels,
the presentation of even a single case can have important
implications locally and internationally [83]. This can
result in a heightened perception of threat to the public
health of the local population and increase concerns
regarding capacity and response of healthcare service
delivery. Recent examples of this include the global public
health control efforts resulting from the 2003 SARS events
[84,85], avian-to-human influenza transmission [86,87],
periodic outbreaks of viral haemorrhagic fevers [88] and
the impact of HIV/AIDS cases in Europe and North Amer-
ica [89,90] acquired abroad.
The continued arrival of new residents from high preva-
lence areas will contribute to the existing disease base of
low incidence migrant-receiving locations. Over time, as
observed with regard to globally prevalent but non-uni-
formly distributed diseases such as tuberculosis [91],
imported cases among migrants and other mobile popu-
lations can come to represent the majority of the case load
in the recipient nation. In these situations, where domes-
tic epidemiology comes to reflect global disease distribu-
tion through the process of migration, health policy
implications become apparent. Long-term healthcare pol-
icy and planning in migrant-receiving nations will have to
encompass an international and more global focus to be
effective. Reliance on historical, domestic epidemiology
for policy implementation in these nations will have lim-
ited relevance when disease volumes and case-burdens
originate beyond the mandate and jurisdiction of
national prevention and control efforts [92]. For example,
hepatitis A infection associated with population mobility
in some western nations has raised concerns for the need
of national domestic immunisation programs to deal with
what is, in fact, the international persistence of the disease
[93].
In terms of non-infectious diseases, migration-associated
pressures result from the need to provide service delivery
in culturally or linguistically sensitive programmes for the
prevention or treatment of illness in migrant communi-
ties. While uncomplicated in principle, the provision of
health promotion or prevention advice, such as that
recently recommended for asthma and atopy in migrant
populations [94], can be both a logistical and resource
challenge [95].Emerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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The reintroduction of diseases into low incidence loca-
tions through migration coupled with the growth of new
populations with wide linguistic and cultural diversity can
create difficulties in recognition, diagnosis and treatment
[96]. In some situations, delayed treatment can have
important consequences. These consequences may
directly affect the patient [97], influence demands on pro-
grams and, for some contagious conditions, challenge the
public health management of the exposed population.
The growth and ease of travel, in conjunction with the
increased numbers of those who are mobile, continues to
raise the likelihood of the global extension and presenta-
tion of many diseases and illnesses. Maintaining sufficient
degrees of clinical suspicion as well as laboratory diagnos-
tic expertise, capacity and access can be costly and compli-
cated. Growing needs for cultural and linguistic
competencies in the health sector increases this complex-
ity [98]. Such preparedness requires the education, train-
ing and maintenance of competence of healthcare
providers and the associated infrastructures for diagnosis
and care [99] (see table 3).
Future impact of population mobility on global health
Negative health outcomes resulting from migration and
population mobility can be expected to increasingly exert
major influences on both national and global health plan-
ning. Mobility is a basic and fundamental component of
the rapidly expanding globalisation process. Analysis sug-
gests that the volume of immigration, travel and the
migration of labour are expected to remain at current lev-
els or increase for the foreseeable future. At the same time,
current regional and global health disparities are antici-
pated to remain or increase, despite the international
desire and efforts to reduce them. Global efforts aimed at
reducing global disparities and impacts of disease and ill
health, such as attempts to achieve the Millennium Devel-
opment Goals [100], are currently underway. These are
long-term initiatives that will take time, resources and
extensive effort to achieve and maintain. The longer inter-
regional disparities in health and health outcomes persist,
the longer they will continue to influence the health of
migrants, as well as mobile and non-mobile populations,
and the greater the challenge and cost will be to effect con-
trol of these conditions.
Historically, the majority of the health issues associated
with migration, or occurring as a result of migration, have
been managed at the national level. This has been accom-
plished through either immigration health activities or
exclusion, or as a component of other domestic health
programs. Demand for these services will remain in some
locations due to specific situational issues or particular
migratory movements. Nationally mandated immigration
health screening [101] and the management of health
issues associated with the Hajj [102] are two examples of
those situations. In other areas, the evolution of travel and
migration has reduced the effectiveness of many national,
point-of-arrival activities. New patterns of population
mobility require reconsideration of the practicality and
viability of border-health inspection for exclusion or con-
tainment strategies. Some nations with large immigration
medical programs maintain specific screening or interven-
tion programs for targeted diseases such as tuberculosis,
syphilis and HIV/AIDS. Accumulating evidence suggests
that more effective outcomes could be obtained through
interventions focused on disease control efforts in source
nations rather than reliance on arrival screening alone
[103]. The globalisation of risks – manifest by the mobil-
Table 3: Health service issues resulting from international population mobility
Immediate Term: Response to Imported/Introduced Illness
Continued/Enhanced need for Clinical/Laboratory Capacities for imported diseases
• Provision of services and facilities
• Sustained laboratory capacity for rare or exotic diseases
• Continuing education of healthcare providers in global health issues
• Post-graduate training in low probability but high impact diseases
• Maintenance of competency in international health issues and response
• Contingency planning and exercise testing of plans
• Global health programs in universities and medical/nursing schools
• Development of specialized reference centers and international networks
Long Term: Response to Growing Foreign Born Population Component
Increasing Demands for Service/Access
Provision of appropriate diagnostic and treatment services
• Modification of training programs for health providers
• Translation and interpretation services
• Increased migration of health professionals from migrant source regions
• Training/certification of migrants who have linguistic skills
• Cultural awareness and sensitivity programs and trainingEmerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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ity of large numbers of individuals flowing across and
between disparities in health environments and disease
prevalence – will require increased investment in globally-
focused resources and management commitments, as
opposed to inward-looking national management strate-
gies and programs.
The increased recognition of the importance of these
issues has already resulted in reconsideration of interna-
tional policy and program activity [104]. Global response
initiatives have been designed, and in some cases imple-
mented, primarily as a result of concerns regarding the
potential adverse population health outcomes posed by
certain infectious disease threats. International collabora-
tion is underway to track and monitor disease in the glo-
bal context. Some of these activities are represented by the
internationalisation of epidemiological surveillance,
reporting and response reflected in the recent revisions to
the International Health Regulations [105].
It is evident that health program and policy planning
processes need to anticipate and manage the future
impacts of population mobility [106]. In several western
nations, migrants and other mobile populations represent
sizeable and growing population sectors. Over time, the
specific health needs and characteristics of these mobile
population cohorts will exert greater influence on the
health sector in the receiving host nations [107]. The
influence of genetic and biological factors in health and
disease will increase in parallel with the size of diverse
migrant populations. At the same time, the impact and
influence of the health environment and epidemiology of
disease at the migrants' place of origin will continue to be
reflected in both migrants and the children of migrant
parents [108] long after the period of immigration.
Addressing these challenges at the national level will
require some changes in the epidemiological context that
is applied to prospective policy development and pro-
gramme management (see table 4). In a globalised world
in which travel and migration represent the experience of
a large and growing population cohort, they can be
expected to assume a standard role as a determination fac-
tor influencing many health outcomes [109]. In a manner
similar to age, sex, genetics, biology, behaviour, and edu-
cational and wealth attainment, the mobility history at
both the individual and population levels will need to
become a routine consideration in healthcare policy,
planning, education, training and service delivery [110].
Similar population-based approaches are already in use in
some of the national and international infectious disease
surveillance and monitoring systems described above
[111]. The analysis and interpretation of the information
collected by those systems has demonstrated the impor-
tance of migration-related travel in terms of imported
tropical infections [112]. The extension of the collection
of the travel and mobility history to non-infectious dis-
ease surveillance is both logical and supported by prelim-
inary study.
Summary
At the national and international level, the epidemiologi-
cal outcomes and issues related to migration can be seen
to result from the predictable effects of population flows
between and across regional disparities and disease prev-
alence differentials. The growing number of migrants of
diverse nature is bridging existing and developing gaps in
health outcome indicators. The dynamics of migration
and population mobility are evolving at a rate that creates
health challenges for existing policy and programme
frameworks that differ from those observed in historic
migratory movements [113].
The net result is an ongoing globalisation of health influ-
ences and indicators currently relevant at both national
and global level. The epidemiological impact of popula-
tion mobility is now evident in a considerable amount of
infectious disease surveillance information [114] and
similar impacts can be anticipated for non-infectious ill-
nesses in immigration receiving nations [115].
As long as global health disparities and prevalence differ-
entials exist, national health programs and policies in
migrant receiving nations will continue to be challenged
by illness and disease arising beyond their jurisdiction.
National control and regulatory systems alone will be
unable to extend their immediate mandate or authority to
the source of the problem. To be effective, the manage-
ment of health issues resulting from population mobility
Table 4: Health policy issues resulting from international population mobility
• National point-of-arrival activities – for example, immigration medical screening programs for specific targeted disease at the airport – will 
become less effective, more costly, and increasingly irrelevant
• International intervention programs for specific diseases at the migrants' country of origin may be more effective than national intervention 
programs dealing with low incidence diseases
• Mobility will become a more important determination factor influencing many health outcomes, along with age, sex, genetics, biology, behaviour 
and educational and wealth attainment
• Mobile population health policy frameworks will increasingly require integration and harmonisation at all jurisdictional levels with international 
economic, trade and security approachesEmerging Themes in Epidemiology 2006, 3:3 http://www.ete-online.com/content/3/1/3
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will require an integration of national and global health
initiatives for both infectious [116] and non-infectious
[117] disease conditions.
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